ZC3H12A and neoplasm: To address the poor persistence and function of ACTs, an in vivo pooled CRISPR-Cas9 mutagenesis screen revealed that T cells with REGNASE-1 ablation exhibited enhanced functionality and improved persistence in tumour clearance.